Warrants13 Sep 2025 12:18
One thing we all need to bear in mind are the warrants. Currently there are 98,542,350 outstanding warrants. Approximately 95,000,000 of the exercisable warrants are at 2p. In the interview Tim done with Zak Mir when cash was mentioned, Tim made reference to the fact that they had released a rns that morning stating warrants had been exercised and fully expected more warrants to be exercised. Of the outstanding warrants Lanstead Capital are the holders of 70 million warrants at 2p. Those warrants can now be exercised for £1.4M, which IMM would receive. At 15p Lanstead Capital would realise a gain of 750% and a profit of £9.1M. Lanstead are managing those funds on behalf of their clients and it would be very naive to think that Lanstead will not take advantage of the current SP and exercise those warrants. They have a duty to do so for their clients. Alora Pharmaceuticals hold 21,818,192 warrants. I think they will exercise their warrants and become shareholders and they could well be one of the companies that ImmuPharma are in negotiations with. A subsidiary of Alora Pharmaceuticals, Avion Pharmaceuticals was granted a license and development agreement for exclusive rights in North America for Lupozor in November 2019. The additional shares although dilutive will add more liquidity to the stock. In the interview I think Tim was giving shareholders the heads up that there are more warrants to be exercised. Good luck all. Atb Popeye.